Table 2.

Five- and 10-year survival estimates by androgen receptor status (N = 1467)

Group5-y survival10-y survival
%95% CI%95% CI
Breast cancer specific survival
AR−8885–928277–86
AR+9593–968886–90
Recurrence-free interval
AR−8581–898075–84
AR+9290–948583–87
Overall survival
AR−8682–907671–81
AR+9190–938077–82